Dramatic interstrain differences in the replication of human cytomegalovirus in scid-hu mice

Journal of Infectious Diseases

Volumn 171, Issue 6, 1995, Pages 1599-1603

  Brown, Janice M ^a,b   Kaneshima, Hideto ^a,b   Subianto, Budi ^a,b   Mocarski, Edward S ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Svstemix Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; ARTICLE; COMBINED IMMUNODEFICIENCY; CYTOMEGALOVIRUS INFECTION; HUMAN CYTOMEGALOVIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE; VIROGENESIS; VIRUS PLAQUE; VIRUS REPLICATION;

ANIMAL; COMPARATIVE STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; MICE; MICE, SCID; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; THYMUS GLAND; VIRUS REPLICATION;

EID: 0029033420     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/171.6.1599     Document Type: Article

References (15)

1. Adler SP. Cytomegalovirus and child day care: risk factors for maternal infection. Pediatr Infect Dis J 1991;10:590-4.
2. Drew WL, Sweet S, Miner RC, Mocarski ES. Multiple infections by cytomegalovirus in patients with acquired immunodeficiency syndrome: documentation by Southern blot hybridization. J Infect Dis 1984;150:952-3.
3. Chou SW. Differentiation of cytomegalovirus strains by restriction analysis of DNA sequences amplified from clinical specimens. J Infect Dis 1990:162:738-42.
4. Plotkin SA, Starr SE, Friedman HM, Gonczol E, Weibel RE. Protective effects of Towne cytomegalovirus vaccine against low-passage cytomegalovirus administered as a challenge. J Infect Dis 1989; 159:8605.
5. Rowe WP, Hartley JW, Waterman S, Turner HC, Huebner RJ. Cytopathogenic agent resembling human salivary gland virus recovered from tissue cultures of human adenoids. Proc Soc Exp BioJ Med 1956;92:418-24.
6. Ibanez CE, Shrier R, Ghazal P, Wiley C, Nelson JA. Human cytomegalovirus productively infects primary differentiated macrophages. J Virol 1991;65:6581-8.
7. Waldman WJ, Roberts WH, Davis DH, Williams MV, Sedmak DD, Stephens RE. Preservation of natural endothelial cytopathogenicity of cytomegalovirus by propagation in endothelial cells. Arch Virol 1991;117:143-64.
8. McCune JM, Namikawa R, Shih CC, Rabin L, Kaneshima H. The SCID-hu mouse: murine model for the analysis of human hemato- lymphoid differentiation and function. Science 1990;247:564-6.
9. Kaneshima H, Shih CC, Namikawa R. et al. Human immunodeficiency virus infection of human lymph nodes in the SCID-hu mouse. Proc Natl Acad Sci USA 1991;88:4523-7.
10. Mocarski ES, Bonyhadi M, Salimi S, McCune JM, Kaneshima H. Human cytomegalovirus in a SCID-hu mouse: thymic epithelial cells are prominent targets of viral replication. Proc Natl Acad Sci USA 1993;90:104-8.
11. Oram JD, Downing RG, Akrigg A. et al. Use of recombinant plasmids to investigate the structure of the human cytomegalovirus genome. J Gen Virol 1982;59:111-29.
12. Chee M, Bankier AT, Beck S, et al. Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD 169. CurrTop Microbiol Immunol 1990:154:125-70.
13. Spector DH, Hock L, Tamashiro JO. Cleavage maps for human cytomegalovirus strain AD 169 for restriction endonucleases £foRI, BglII, and HindUl. J Virol 1982;42:558-82.
14. Kaye J, Browne H, Stoffel M, Minson T. The UL16 gene of human cytomegalovirus encodes a glycoprotein that is dispensable for growth in vitro. J Virol 1992;66:6609-15.
15. Browne H, Churcher M, Minson T. Construction and characterization of a human cytomegalovirus mutant with the ULI8 (class I homolog) gene deleted. J Virol 1992;66:6784-7.